Эта страница была переведена автоматически, точность перевода не гарантируется. Пожалуйста, обратитесь к английской версии для исходного текста.

Flourishing for Peace

15 ноября 2026 г. обновлено: Universidad del Sinú - Elías Bechara Zainúm

Flourishing for Peace Curriculum (Currículo de Florecimiento Para la Paz)

This study is a six-arm individually randomized group-treated (IRGT) trial comparing five16-week standalone flourishing curricula conditions with a control condition consisting of the regular curriculum. Participants will be individually randomized to one of the six conditions. Self-report variables and heart rate variability (HRV) data will be assessed at four time points: T1 (baseline, before the curriculum begins), T2 (8-week midterm), T3 (16-week, at the end of the curriculum), and T4 (beginning of next term), with the main outcome testing changes between T1 and T3. Primary outcomes include the lnRMSSD as a measure of HRV and the overall self-reported flourishing score. Secondary outcomes include 20 domain specific psychological scales and two other HRV measures (SDNN, and mean heart rate). Course-specific knowledge tests will also be administered to gauge participant engagement and course effectiveness. Study results will be reported in accordance with the Consolidated Standards of Reporting Trials (CONSORT) guidelines for non-pharmacological interventions.

Обзор исследования

Тип исследования

Интервенционный

Регистрация (Оцененный)

1050

Фаза

  • Непригодный

Контакты и местонахождение

В этом разделе приведены контактные данные лиц, проводящих исследование, и информация о том, где проводится это исследование.

Контакты исследования

Места учебы

Критерии участия

Исследователи ищут людей, которые соответствуют определенному описанию, называемому критериям приемлемости. Некоторыми примерами этих критериев являются общее состояние здоровья человека или предшествующее лечение.

Критерии приемлемости

Возраст, подходящий для обучения

18 лет и старше (Взрослый, Пожилой взрослый)

Принимает здоровых добровольцев

Да

Полы, имеющие право на обучение

Все

Описание

Inclusion Criteria:

  • (a) enrollment as a university student at UniSinu; (b) intention to remain in the campus area for at least 12 months and express a commitment to try to remain engaged in the study from beginning to end; and (c) ability to read, speak, and understand Spanish.

Exclusion Criteria:

  • No

Учебный план

В этом разделе представлена ​​подробная информация о плане исследования, в том числе о том, как планируется исследование и что оно измеряет.

Как устроено исследование?

Детали дизайна

  • Основная цель: Фундаментальная наука
  • Распределение: Рандомизированный
  • Интервенционная модель: Параллельное назначение
  • Маскировка: Тройной

Оружие и интервенции

Группа участников / Армия
Вмешательство/лечение
Экспериментальный: Resilience and Self-Control

This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts.

Resilience and Self-Control

Экспериментальный: Stress, Coping, and Forgiveness

This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts.

Stress, Coping, and Forgiveness

Экспериментальный: Mindfulness and Meaning and Purpose

This flourishing curriculum combines two courses, and is delivered as a stand-alone, 16-week classroom seminar. Mindfulness will be taught in 8 of the 16 weeks and Meaning and Purpose will be taught in another 8 weeks. Contents incorporate lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts.

Mindfulness and Meaning and Purpose

Экспериментальный: Quality of Relationships for Peace and Positive Emotions

This flourishing curriculum combines two courses, and is delivered as a stand-alone, 16-week classroom seminar. Quality of Relationships for Peace will be taught in 8 of the 16 weeks and Positive Emotions will be taught in another 8 weeks. Contents incorporate lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts.

Quality of Relationships for Peace and Positive Emotions

Экспериментальный: Emotional Intelligence, Forgiveness, and Spirituality

This flourishing curriculum is delivered as a stand-alone, 16-week classroom seminar incorporating lectures, experiential activities, and structured discussions. The content of this curriculum was developed by subject-matter experts.

Emotional Intelligence, Forgiveness, and Spirituality

Активный компаратор: Regular course

Participants assigned to the control condition will continue with their regular university coursework but complete the same measures as the intervention conditions.

Regular course

Что измеряет исследование?

Первичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
Overall Flourishing: Flourish Measure
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Use the total score across 10 items of the Flourish measure developed by Tyler VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
lnRMSSD
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Heart rate variability (HRV) will be collected using a validated chest-strap sensor ( the Polar H10; Polar Electro, Kempele, Finland) during standardized resting assessments. The natural logarithm of the root mean square of successive differences between normal RR intervals (lnRMSSD), a time-domain measure of short-term heart rate variability and vagal/parasympathetic regulation, will be used as the primary HRV outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Вторичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
Happiness and Life Satisfaction: subscale of Flourish Measure
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Mental and Physical Health: subscale of Flourish Measure
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Meaning and Purpose: subscale of Flourish Measure
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Character and Virtue: subscale of Flourish Measure
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Close Social Relationships: subscale of Flourish Measure
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

subscale of the Flourish measure of the primary outcome developed by VanderWeele. Scale score ranges from 0 to 10. Higher score indicates better outcome.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Depression symptoms: Patient Health Questionnaire-9 (PHQ-9)
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 0 to 3. Higher score indicates more severe depressive symptoms.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Anxiety Symptoms: Generalized Anxiety Disorder-7 (GAD-7)
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 0 to 3. Higher scores more severe anxiety symptoms.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
The Short Stress Overload Scale
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher stress.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Coherence: subscale of the Three Dimensional Meaning in Life Scale (3DM)
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 7. Higher score indicates higher meaning.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Purpose: subscale of the Three Dimensional Meaning in Life Scale (3DM)
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 7. Higher score indicates higher meaning.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Significance: subscale of the Three Dimensional Meaning in Life Scale (3DM)
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 7. Higher score indicates higher meaning.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Trait Forgivingness Scale
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher forgiveness.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Trait Humility: subscale of Relational Humility Scale
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher humility.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Cognitive and Affective Mindfulness Scale-Revised (CAMS-R)
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 4. Higher score indicates higher mindfulness.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Brief Self-Control Scale
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher self-control

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Brief Resilience Scale
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher resilience.

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Loneliness: NIH Toolbox Adult Social Relationship Scales
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher level of loneliness

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Transcendent Spirituality: subscale of Trait Sources of Spirituality Scale
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher level of spirituality

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Persevering Hope Scale
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 1 to 5. Higher score indicates higher level of hope

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Coping Self-Efficacy Scale
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Scale score ranges from 0 to 10. Higher score indicates higher level of self-efficacy

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
SDNN
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Standard Deviation of Normal-to-Normal intervals, another HRV measure

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up
Mean Heart Rate
Временное ограничение: T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Mean Heart Rate

T1 Baseline, T2 End of 8 weeks, T3 End of 16 weeks, T4 6-month Follow-up

Соавторы и исследователи

Здесь вы найдете людей и организации, участвующие в этом исследовании.

Даты записи исследования

Эти даты отслеживают ход отправки отчетов об исследованиях и сводных результатов на сайт ClinicalTrials.gov. Записи исследований и сообщаемые результаты проверяются Национальной медицинской библиотекой (NLM), чтобы убедиться, что они соответствуют определенным стандартам контроля качества, прежде чем публиковать их на общедоступном веб-сайте.

Изучение основных дат

Начало исследования (Оцененный)

1 января 2027 г.

Первичное завершение (Оцененный)

1 августа 2027 г.

Завершение исследования (Оцененный)

1 декабря 2027 г.

Даты регистрации исследования

Первый отправленный

15 ноября 2026 г.

Впервые представлено, что соответствует критериям контроля качества

15 ноября 2026 г.

Первый опубликованный (Действительный)

20 ноября 2026 г.

Обновления учебных записей

Последнее опубликованное обновление (Действительный)

20 ноября 2026 г.

Последнее отправленное обновление, отвечающее критериям контроля качества

15 ноября 2026 г.

Последняя проверка

1 ноября 2026 г.

Дополнительная информация

Термины, связанные с этим исследованием

Другие идентификационные номера исследования

  • Acta No. 005 de 2025

Планирование данных отдельных участников (IPD)

Планируете делиться данными об отдельных участниках (IPD)?

НЕТ

Информация о лекарствах и устройствах, исследовательские документы

Изучает лекарственный продукт, регулируемый FDA США.

Нет

Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.

Нет

Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .

Подписаться